272 Capital LP Trims Holdings in KORU Medical Systems, Inc. (NASDAQ:KRMD)

272 Capital LP reduced its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 96.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 9,572 shares of the company’s stock after selling 292,543 shares during the quarter. 272 Capital LP’s holdings in KORU Medical Systems were worth $37,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. 683 Capital Management LLC purchased a new position in shares of KORU Medical Systems during the 4th quarter worth $340,000. Jane Street Group LLC lifted its position in KORU Medical Systems by 67.0% during the fourth quarter. Jane Street Group LLC now owns 68,923 shares of the company’s stock worth $265,000 after buying an additional 27,664 shares during the period. Schonfeld Strategic Advisors LLC acquired a new stake in KORU Medical Systems in the 4th quarter worth about $143,000. First Light Asset Management LLC grew its holdings in KORU Medical Systems by 5.7% in the 4th quarter. First Light Asset Management LLC now owns 5,915,434 shares of the company’s stock valued at $22,774,000 after buying an additional 316,509 shares during the period. Finally, Northern Trust Corp increased its stake in shares of KORU Medical Systems by 11.2% during the 4th quarter. Northern Trust Corp now owns 79,175 shares of the company’s stock valued at $305,000 after acquiring an additional 7,967 shares during the last quarter. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Price Performance

KRMD opened at $2.75 on Friday. KORU Medical Systems, Inc. has a 52-week low of $1.86 and a 52-week high of $5.05. The company has a 50 day moving average of $2.70 and a two-hundred day moving average of $3.37. The company has a market cap of $126.89 million, a P/E ratio of -11.00 and a beta of 0.87. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01.

Analyst Ratings Changes

Several research firms recently issued reports on KRMD. Lake Street Capital raised their target price on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research report on Tuesday, January 14th. B. Riley upgraded shares of KORU Medical Systems to a “strong-buy” rating in a report on Thursday, March 13th. Piper Sandler restated a “neutral” rating and set a $4.50 price objective on shares of KORU Medical Systems in a report on Friday, February 14th. Finally, Craig Hallum lifted their target price on KORU Medical Systems from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $4.70.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.